Boehringer Ingelheim Announces $35 Monthly Price Cap on Inhalers for Asthma, COPD Patients
HCPLive
MARCH 7, 2024
On March 07, 2024, Boehringer Ingelheim announced it would be instituting a $35 per month out-of-pocket cost cap for its portfolio of inhaler products, with this cap going into effect on June 01, 2024.
Let's personalize your content